Sakar Healthcare Limited
NSE SAKAR.NS
Sakar Healthcare Limited Price to Earnings Ratio (P/E) on February 07, 2025: 49.33
-
Sakar Healthcare Limited 52-week high Price to Earnings Ratio (P/E) is 70.29 on February 09, 2024, which is 42.49% above the current Price to Earnings Ratio (P/E).
-
Sakar Healthcare Limited 52-week low Price to Earnings Ratio (P/E) is 49.33 on February 07, 2025, which is 0.00% below the current Price to Earnings Ratio (P/E).
-
Sakar Healthcare Limited average Price to Earnings Ratio (P/E) for the last 52 weeks is 59.25.
| Date | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) | Dividend Yield |
|---|
Don’t Miss A Beat
| CEO | Mr. Sanjay Surendra Shah |
| IPO Date | March 16, 2017 |
| Location | India |
| Headquarters | 406, Silver Oaks Comm. Complex |
| Employees | 325 |
| Sector | Healthcare |
| Industries | |
Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable SVP in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in approximately 22 therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytocic, analgesic, antiemetic, antipsychotic, antifungal, PPI, anticonvulsant, anti-inflammatory, antihistamine, and multi vitamins. The company also exports its products to approximately 38 countries, including Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.
Past 5 years
StockViz Staff
February 8, 2025
Any question? Send us an email